Evidence map›Paper›PMID 41215761›Full record

ArticleMaterials today. Bio2025

Polydopamine-chitosan coated biofilm-state

Yinxue Liu, Yisuo Liu, Lu Jiang, Tongjie Liu, Zhe Zhang, Pimin Gong, Huaxi Yi

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yinxue LiuCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Yisuo LiuCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Lu JiangCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Tongjie LiuCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Zhe ZhangCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Pimin GongCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.
Huaxi YiCollege of Food Science and Engineering, Ocean University of China, Qingdao, Shandong Province 266404, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) involves chronic intestinal inflammation and epithelial barrier disruption. While probiotics offer therapeutic potential, planktonic (PLA) forms suffer from poor viability, limited adhesion, and suboptimal efficacy. Biofilm-state (BIO) probiotics can exert probiotic functions effectively, yet inflammation impairs the conditions necessary for probiotics to form biofilm in the intestine. Direct delivery of biofilm-state probiotics offers a more effective strategy. Here, an innovative probiotic targeted delivery system is developed by integrating biofilm-state

Indexed as

BiofilmChitosanInflammatory bowel diseasePolydopamineProbioticsTargeted therapy

Identifiers

PMID41215761
PMCPMC12596216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.